Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ASP Isotopes (ASPI) Cash & Equivalents (2021 - 2025)

ASP Isotopes has reported Cash & Equivalents over the past 5 years, most recently at $285.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 361.4% year-over-year to $285.6 million; the TTM value through Dec 2025 reached $285.6 million, up 361.4%, while the annual FY2025 figure was $285.6 million, 361.4% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $285.6 million at ASP Isotopes, up from $113.9 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $285.6 million in Q4 2025 and troughed at $431565.0 in Q3 2022.
  • A 5-year average of $42.4 million and a median of $7.9 million in 2023 define the central range for Cash & Equivalents.
  • Biggest five-year swings in Cash & Equivalents: dropped 19.11% in 2022 and later skyrocketed 2155.18% in 2024.
  • Year by year, Cash & Equivalents stood at $3.0 million in 2021, then decreased by 19.11% to $2.4 million in 2022, then surged by 231.0% to $7.9 million in 2023, then surged by 682.63% to $61.9 million in 2024, then soared by 361.4% to $285.6 million in 2025.
  • Business Quant data shows Cash & Equivalents for ASPI at $285.6 million in Q4 2025, $113.9 million in Q3 2025, and $67.7 million in Q2 2025.